Related Experiment Video
Updated: May 12, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
[Clinical guidelines for the prevention of infective endocarditis]
J Pérez-Lescure Picarzo1, D Crespo Marcos1, F Centeno Malfaz2
1Área de Pediatría y Neonatología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España.
Insights
New guidelines reduce antibiotic prophylaxis for infective endocarditis (IE) prevention due to limited evidence and antibiotic resistance concerns. Healthcare professionals should follow updated recommendations for at-risk patients and procedures.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Context:
- Updated guidelines for infective endocarditis (IE) prevention from AHA and ESC.
- Significant changes in IE prophylaxis recommendations due to lack of evidence and antibiotic resistance.
- Focus on reducing indications for antibiotic prophylaxis in at-risk patients and procedures.
Purpose:
- To outline the latest recommendations for preventing infective endocarditis.
- To inform healthcare professionals about revised antibiotic prophylaxis guidelines.
- To promote evidence-based decision-making in IE prevention.
Summary:
- The article presents revised guidelines for infective endocarditis (IE) prevention, harmonized by the Spanish Society of Paediatric Cardiology and Congenital Heart Disease, based on AHA and ESC recommendations.
- Key changes include a significant reduction in the indications for antibiotic prophylaxis, addressing concerns about evidence of effectiveness and the rise of antibiotic resistance.
- These updated clinical practice guidelines aim to aid healthcare professionals in making informed decisions regarding IE prevention strategies.
Impact:
- Facilitates updated clinical decision-making for healthcare professionals regarding IE prevention.
- Contributes to antimicrobial stewardship by reducing unnecessary antibiotic use.
- Aims to improve patient outcomes by focusing prophylaxis on highest-risk scenarios.
Abstract:
This article sets out the recommendations for the prevention of infective endocarditis (IE), contained in the guidelines developed by the American Heart Association (AHA) and the European Society of Cardiology (ESC), from which the recommendations of the Spanish Society of Paediatric Cardiology and Congenital Heart Disease have been agreed. In recent years, there has been a considerable change in the recommendations for the prevention of IE, mainly due to the lack of evidence on the effectiveness of antibiotic prophylaxis in prevention, and the risk of the development of antibiotic resistance. The main change is a reduction of the indications for antibiotic prophylaxis, both in terms of patients and procedures considered at risk. Clinical practice guidelines and recommendations should assist health professionals in making clinical decisions in their daily practice. However, the ultimate judgment regarding the care of a particular patient must be taken by the physician responsible.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Mitral Stenosis III: Medical Management

